01 Sep 2022
Research published in the Journal of the National Cancer Institute indicates that men with advanced prostate cancer who are prescribed abiraterone and enzalutamide may have an increased risk of metabolic and cardiovascular problems.
Healio
New study suggests interacting with dogs can reduce cortisol levels
15 Mar 2024
Diabetes risk may be reduced by prioritising plant-based food
15 Mar 2024
Obesity in primary school aged girls linked to high incidence of musculoskeletal symptoms
15 Mar 2024
Risk of endometrial cancer associated with endocrine disrupting chemicals (EDCs)
15 Mar 2024